Potential of E-Learning Interventions and Artificial Intelligence-Assisted Contouring Skills in Radiotherapy: The ELAISA Study.


Journal

JCO global oncology
ISSN: 2687-8941
Titre abrégé: JCO Glob Oncol
Pays: United States
ID NLM: 101760170

Informations de publication

Date de publication:
Aug 2024
Historique:
medline: 5 9 2024
pubmed: 5 9 2024
entrez: 5 9 2024
Statut: ppublish

Résumé

Most research on artificial intelligence-based auto-contouring as template (AI-assisted contouring) for organs-at-risk (OARs) stem from high-income countries. The effect and safety are, however, likely to depend on local factors. This study aimed to investigate the effects of AI-assisted contouring and teaching on contouring time and contour quality among radiation oncologists (ROs) working in low- and middle-income countries (LMICs). Ninety-seven ROs were randomly assigned to either manual or AI-assisted contouring of eight OARs for two head-and-neck cancer cases with an in-between teaching session on contouring guidelines. Thereby, the effect of teaching (yes/no) and AI-assisted contouring (yes/no) was quantified. Second, ROs completed short-term and long-term follow-up cases all using AI assistance. Contour quality was quantified with Dice Similarity Coefficient (DSC) between ROs' contours and expert consensus contours. Groups were compared using absolute differences in medians with 95% CIs. AI-assisted contouring without previous teaching increased absolute DSC for optic nerve (by 0.05 [0.01; 0.10]), oral cavity (0.10 [0.06; 0.13]), parotid (0.07 [0.05; 0.12]), spinal cord (0.04 [0.01; 0.06]), and mandible (0.02 [0.01; 0.03]). Contouring time decreased for brain stem (-1.41 [-2.44; -0.25]), mandible (-6.60 [-8.09; -3.35]), optic nerve (-0.19 [-0.47; -0.02]), parotid (-1.80 [-2.66; -0.32]), and thyroid (-1.03 [-2.18; -0.05]). Without AI-assisted contouring, teaching increased DSC for oral cavity (0.05 [0.01; 0.09]) and thyroid (0.04 [0.02; 0.07]), and contouring time increased for mandible (2.36 [-0.51; 5.14]), oral cavity (1.42 [-0.08; 4.14]), and thyroid (1.60 [-0.04; 2.22]). The study suggested that AI-assisted contouring is safe and beneficial to ROs working in LMICs. Prospective clinical trials on AI-assisted contouring should, however, be conducted upon clinical implementation to confirm the effects.

Identifiants

pubmed: 39236283
doi: 10.1200/GO.24.00173
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2400173

Auteurs

Mathis Ersted Rasmussen (ME)

Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.

Kamal Akbarov (K)

International Atomic Energy Agency, Vienna, Austria.

Egor Titovich (E)

International Atomic Energy Agency, Vienna, Austria.

Jasper Albertus Nijkamp (JA)

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Wouter Van Elmpt (W)

MAASTRO clinic, Maastricht University Medical Centre, Maastricht, the Netherlands.

Hanne Primdahl (H)

Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.

Pernille Lassen (P)

Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.

Jon Cacicedo (J)

Department of Radiation Oncology, Cruces University Hospital, Bilbao, Spain.

Lisbeth Cordero-Mendez (L)

International Atomic Energy Agency, Vienna, Austria.

A F M Kamal Uddin (AFMK)

Labaid Cancer Hospital and Super Speciality Centre, Dhaka, Bangladesh.

Ahmed Mohamed (A)

National Cancer Institute, University of Gezira, Wad Madani, Sudan.

Ben Prajogi (B)

Cipto Mangunkusumo Hospital, Jakarta, Indonesia.

Kartika Erida Brohet (KE)

Dharmais Cancer Hospital, Jakarta, Indonesia.

Catherine Nyongesa (C)

Kenyatta National Hospital, Nairobi, Kenya.

Darejan Lomidze (D)

Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic, Tbilisi, Georgia.

Gisupnikha Prasiko (G)

Nepal Cancer Hospital and Research Center, Lalitpur, Nepal.

Gustavo Ferraris (G)

Centro de Radioterapiya dean Funes, Cordoba, Argentina.

Humera Mahmood (H)

Atomic Energy Cancer Hospital NORI, Islamabad, Pakistan.

Igor Stojkovski (I)

University Clinic of Radiotherapy and Oncology, Skopje, Macedonia.

Isa Isayev (I)

National Center of Oncology, Baku, Azerbaijan.

Issa Mohamad (I)

King Hussein Cancer Center, Amman, Jordan.

Leivon Shirley (L)

Christian Institute of Health Science and Research, Dimapur, India.

Lotfi Kochbati (L)

Hospital Abderrahmen Mami, Ariana, Tunesia.

Ludmila Eftodiev (L)

Moldavian Oncology Institute, Chisinau, Moldova.

Maksim Piatkevich (M)

N. N. Alexandrov National Cancer Centre of Belarus, Minsk, Belarus.

Maria Matilde Bonilla Jara (MM)

Hospital México, San José, Costa Rica.

Orges Spahiu (O)

Mother Tereza Hospital, Tirana, Albania.

Rakhat Aralbayev (R)

National Centre of Oncology and Hematology, Bishkek, Kyrgyzstan.

Raushan Zakirova (R)

Center of Nuclear Medicine and Oncology, Semey, Kazakhstan.

Sandya Subramaniam (S)

Hospital Kuala Lumpur, Kuala Lumpur, Malaysia.

Solomon Kibudde (S)

Uganda Cancer Institute, Kampala, Uganda.

Uranchimeg Tsegmed (U)

National Cancer Center of Mongolia, Ulaanbaatar, Mongolia.

Stine Sofia Korreman (SS)

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Jesper Grau Eriksen (JG)

Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH